ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 0366 • ACR Convergence 2024

    Factors Associated with Participation in Rheumatology Clinical Trials: A UK-based Study

    Koushan Kouranloo1 and Chris Wincup2, 1Internal Medicine Resident., London, United Kingdom, 2King's College Hospital, London, United Kingdom

    Background/Purpose: Clinicians are encouraged to consider patient preferences for offering face-to-face vs virtual consultations. This adaptability is particularly important to rheumatologists caring for patients with…
  • Abstract Number: 1043 • ACR Convergence 2024

    A Prospective Study on Early Diagnosis of Inflammatory Rheumatic Diseases Using an Enhanced Online Questionnaire System (RhePort 1.3)

    Cay von Der Decken1, Stefan Kleinert2, Matthias Englbrecht3, Kirsten Karberg4, Georg Gauler5, Susanna Spaethling-Mestekemper6, Christoph Kuhn7, Wolfgang Vorbrueggen8, Martin Welcker9 and Peter Bartz-Bazzanella10, 1Klinik für Internistische Rheumatologie, Rhein-Maas-Klinik Wuerselen, Würselen, 2Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN), Erlangen, Germany, 3Freelance Healthcare Data Scientist, Eckental, 4Rheumatologisches Versorgungszentrum Steglitz, Berlin, Germany, 5rheumapraxis, Osnabrück, Germany, 6Rheumapraxis Muenchen, Muenchen, Germany, 7Praxis für Rheumatologie, Karlsruhe, Germany, 8Verein zur Foerderung der Rheumatologie e.V, Wuerselen, Germany, 9Medizinisches Versorgungszentrum für Rheumatologie Dr. M. Welcker GmbH, Planegg, Germany, 10Rhein-Maas Klinikum, Wuerselen, Germany

    Background/Purpose: The RhePort system, accessible via "www.RhePort.de" and featuring an integrated questionnaire with a specialized algorithm, aims to facilitate the early diagnosis of inflammatory rheumatic…
  • Abstract Number: 1720 • ACR Convergence 2024

    Herpes Zoster Risk Following Initiation of Immunosuppressive Therapy Among Adults with Rheumatic Disease

    Justin Gatwood1, Yong Zhu2, Andrea Steffens2, Stephanie Gallagher2, Mary DuCharme2 and Nikita Stempniewicz1, 1GSK, Philadelphia, PA, 2Optum Life Sciences, Eden Prairie, MN

    Background/Purpose: Previous studies have demonstrated that the risk of herpes zoster (HZ) among adults with rheumatic disease, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA),…
  • Abstract Number: 2605 • ACR Convergence 2024

    Clarifying Misbeliefs & Resolving Decisional Conflicts About Hydroxychloroquine (HCQ) Through a Shared Decision-Making Tool (HCQ-SAFE©)

    Shivani Garg1, Jay Patel1, Sancia Ferguson2, Betty Chewning3, Shelby Gomez4, Jon keevil5, David Gazeley6, Patricia Tellez-Giron1 and Christie Bartels7, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2University of Wisconsin, Madison, Madison, WI, 3University of Wisconsin, School of Pharmacy, Madison, 4UW Health, Madison, 5N/A, Madison, 6Medical College of Wisconsin, Wauwatosa, WI, 7University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Treatment of lupus (or SLE) is complex, especially for young patients who are committed to take hydroxychloroquine (HCQ) lifelong, which carries some risk, albeit…
  • Abstract Number: 0374 • ACR Convergence 2024

    How Do Patient Decision Aids Enable Purposeful Shared Decision-Making in Rheumatology? An Integrative Review

    Ibiyemi Oke1, Ruoning Ni1 and Bharat Kumar2, 1UNVERSITY OF IOWA HOSPITALS AND CLINICS, Iowa City, IA, 2University of Iowa Hospitals and Clinics, Iowa City, IA

    Background/Purpose: Shared decision-making (SDM) is a process in which patients and clinicians work together to make health care decisions.  Purposeful SDM (PSDM) is a problem-based…
  • Abstract Number: 1046 • ACR Convergence 2024

    Shifting Paradigms in Drug Spending: A Study of Medicare Part D versus Emerging Pharmacy Models in Rheumatology

    Katherine Schoeffler, Stephanie Beveridge, Max Bouvette, Veera Durga Vaishnavi Kurra, Reema Moussa, Ryan Johnson, Camille Goerend, Nimrah Bader and Ryan Nipp, University of Oklahoma College of Medicine, Oklahoma City, OK

    Background/Purpose: Recent policy changes and competitive alternative drug pricing models present the potential for medication cost savings. In this study, we sought to assess the…
  • Abstract Number: 1721 • ACR Convergence 2024

    Recombinant Zoster Vaccine Uptake in US Adults with Rheumatic Disease: A Mixed Methods Analysis

    Justin Gatwood1, Catherine McGuiness2, Marie Yasuda2, Chi-Chang Chen2, Vasudha Gupta3 and Nikita Stempniewicz1, 1GSK, Philadelphia, PA, 2IQVIA, Wayne, PA, 3IQVIA, Durham, NC

    Background/Purpose: Compared to the immunocompetent US population ≥50 years, adults with rheumatic diseases are at increased risk for herpes zoster (HZ). To address this risk,…
  • Abstract Number: 2609 • ACR Convergence 2024

    Drivers of Infliximab Biosimilar Uptake: A Comparative Analysis of New Biosimilar Initiations versus Switching in a National Rheumatology Registry

    Eric Roberts1, Nick Bansback2, Chien-Wen Tseng3, Steve Shiboski4, Jing Li5, Gabriela Schmajuk6 and Jinoos Yazdany7, 1University of California, San Francisco, SF, CA, 2University of British Columbia, Vancouver, BC, Canada, 3University of Hawai'i John A. Burns School of Medicine, Honolulu, 4University of California, San Francisco, San Francisco, 5University of California, San Francisco, San Francisco, CA, 6UCSF / SFVA, San Francisco, CA, 7UCSF, San Francisco, CA

    Background/Purpose: Biosimilars hold promise for reducing pharmaceutical expenditures, however uptake has lagged. We analyzed the variability in new biosimilar starts and switching from bio-originator infliximab…
  • Abstract Number: 0375 • ACR Convergence 2024

    Patient Outcomes During the Implementation of a Patient Decision-Aid for a Diverse Population of Systemic Lupus Erythematosus: A Study in 15 U.S. Rheumatology Clinics

    Jasvinder Singh1, Larry Hearld2, Walter Chatham3, Sonali Narain4, Narender Annapureddy5, Diane Kamen6, Kimberly Trotter7, vikas Majithia8, Zineb Aouhab9, Swamy Venuturupalli10, Daniel Wallace11, rosalind Ramsey-Goldman12, Alfred Kim13, Maureen McMahon14, S. Sam Lim15, Kalpana Bhairavarasu16, Alexa Meara17, Kenneth Kalunian18 and Cathy Lee Ching19, 1Baylor College of Medicine, Birmingham, AL, 2University of Alabama at Birmingham (UAB), Birmingham, AL, 3University of Nevada, Las Vegas, Las Vegas, NV, 4Northwell Health, Great Neck, NY, 5Vanderbilt University Medical Center, Nashville, TN, 6Medical University of South Carolina, Charleston, SC, 7University of Chicago, Chicago, IL, 8University of Missisippi Medical Center (UMC), Jackson, MS, 9Loyola University Medical Center, Oak Brook, IL, 10Attune Health, Beverly Hills, CA, 11Cedars Sinai Medical Center, Studio City, CA, 12Northwestern University, Chicago, IL, 13Washington University School of Medicine, Division of Rheumatology, Department of Medicine, St Louis, MO, 14UCLA David Geffen School of Medicine, Los Angeles, CA, 15Emory University, Atlanta, GA, 16Baylor College of Medicine, Sugar Land, TX, 17The Ohio State University Wexner Medical Center, COLUMBUS, OH, 18University of California San Diego, La Jolla, CA, 19UMMC, Jackson, MS

    Background/Purpose: To implement a self-administered patient decision-aid (PtDA) for lupus in outpatient clinics, assess its reach/penetration within each clinic, and examine patient outcomesMethods: An effective…
  • Abstract Number: 1052 • ACR Convergence 2024

    Challenges and Opportunities in Post-Pandemic Remote Therapeutic Monitoring for Musculoskeletal Disease

    Angela Degrassi1, Jeffrey Curtis2, David Curtis1, Kelly Gavigan1, Laura Stradford3, Shelley Fritz4, Sandeep Sodhi5 and Shilpa Venkatachalam6, 1Global Healthy Living Foundation, Upper Nyack, NY, 2University of Alabama at Birmingham, Hoover, AL, 3Global Healthy Living Foundation, Nyack, NY, 4Global Healthy Living Foundation, Kalaheo, HI, 5Illumination Health, Hoover, AL, 6Global Healthy Living Foundation, New York, NY

    Background/Purpose: Remote Therapeutic Monitoring (RTM) connects patients to their healthcare provider using a smartphone app with or without a physiologic biosensor device in an insurance-reimbursable…
  • Abstract Number: 1724 • ACR Convergence 2024

    Performance of a Novel Cardiovascular Risk Calculator in Rheumatoid Arthritis

    Tate Johnson1, Halie Frideres2, Punyasha Roul3, Yangyuna Yang1, Joshua Baker4, Sauer brian5, grant Cannon6, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC Department of Rheumatology, Omaha, NE, 3UNMC, Omaha, NE, 4University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6University of Utah and Salt Lake City VA, Salt Lake City, UT

    Background/Purpose: Existing cardiovascular disease (CVD) risk calculators have inadequately estimated CVD risk in people with rheumatoid arthritis (RA). The American Heart Association (AHA) recently developed…
  • Abstract Number: 2610 • ACR Convergence 2024

    Treatment Concordance of Asynchronous Virtual Visits Compared to Traditional In-person Visits in Patients with Rheumatoid Arthritis: Results of the Prospective, Multi-center, Randomized Controlled TELERA Trial

    Johannes Knitza1, Johanna Mucke2, Manuel Grahammer3, Sebastian Kuhn1, Nicolas Vuillerme4, Felix Muehlensiepen5, Gerhard Krönke6, Georg Schett7, Ann-Christin Pecher8 and Martin Krusche9, and the TELERA Study Group, 1Institute for Digital Medicine, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany, Marburg, Germany, 2Heinrich-Heine-University, Duesseldorf, Germany, 3ABATON, Berlin, Germany, 4AGEIS, Université Grenoble Alpes, 38000 Grenoble, France, Grenoble, France, 5Center for Health Services Research, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany, Berlin, Germany, 6Rheumatology, Charité, Berlin, Germany, 7Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 8Interdisciplinary Center of Rheumatic Diseases (INDIRA), University Hospital Tuebingen, Tuebingen, Germany, Tübingen, Germany, 9III Department of Medicine, Division of Rheumatology and Systemic Inflammatory Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, Germany

    Background/Purpose: Access to rheumatology care is becoming increasingly limited, necessitating a re-evaluation of patient pathways. The objective of this study was to evaluate a new…
  • Abstract Number: 0137 • ACR Convergence 2024

    The Problem of Pain in Rheumatology: Sociodemographic and Disease-related Correlates of Agreement Between Structured Data Elements and Clinical Notes in Chronic Pain Documentation Practices in EHR

    Tahmina Begum1, Bhagyavalli Veeranki1, Ogenna Chike1 and Titilola Falasinnu2, 1Stanford School of Medicine, Stanford, 2Stanford School of Medicine, Palo Alto, CA

    Background/Purpose: To create greater precision in case definitions for chronic pain in EHRs, we recently identified 15 different case definitions for chronic pain using structured…
  • Abstract Number: 0437 • ACR Convergence 2024

    Describing Maternal Outcomes Among Veterans with a History of Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Deirdre Quinn1, Florentina Sileanu1, Gregory Procario1, Shannon Mitchell1 and Mehret Birru Talabi2, 1VA Pittsburgh Healthcare System, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Veterans who utilize Department of Veterans Affairs (VA) maternity benefits, nearly half (42%) of whom represent racial or ethnic minority groups, have a high…
  • Abstract Number: 1053 • ACR Convergence 2024

    Pilot Intervention to Improve Medication Adherence Among Patients with Rheumatic Diseases

    Kai Sun1, Lisa Carnago2, Isaac Smith3, Brian Andonian1, Stephen Balevic1, Ankoor Shah1, Catherine Sims4, Kathryn Pollak5, Amy Corneli5, Hayde Bosworth5 and Megan Clowse6, 1Duke University, Durham, NC, 2Duke Health, Hillsborough, NC, 3Duke University Hospital, Durham, NC, 4Duke University, Knightdale, NC, 5Duke University, Durham, 6Duke University, Chapel Hill, NC

    Background/Purpose: Medication nonadherence is as high as 75% among patients with rheumatic diseases, leading to increased morbidity, mortality, and cost. Existing adherence interventions tend to…
  • 1
  • 2
  • 3
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology